Introduction
Nutritional de®ciencies are very frequent in advanced cirrhosis due to a wide array of metabolic disturbances associated with this disease. Malnutrition has a negative impact on the outcome of these patients, which is particularly relevant for those who are candidates for liver transplantation. As in previous years, the aim of this article is to scan the papers published during the last year (from spring 1999 to spring 2000) in the ®eld of nutritional and metabolic derangements and their treatment in human cirrhosis and liver transplantation. Papers have been published related to the use of body composition measurement techniques in cirrhosis, and the assessment of energy requirements in these patients. New important insights into some metabolic consequences of liver transplantation (e.g. reversal of insulin resistance, increase in bone loss) have become available. Other papers have dealt with fatty acid and antioxidant status in cirrhosis. As in previous years, relevant contributions providing the answers to important questions in the ®eld of nutritional support therapy in chronic liver diseases are lacking.
Assessing body composition and nutritional requirements in cirrhosis
Diagnosing malnutrition is not dif®cult in cirrhotic patients with advanced disease who are obviously cachectic. However, nutritional derangement may occur in earlier stages of the disease [1] . In this setting, the diagnosis of malnutrition may be more dif®cult and requires the use of reliable objective parameters.
Traditional bedside methods for nutritional assessment, such as anthropometry and plasma protein concentrations, are still most often used for this purpose, despite the fact that their reliability has been repeatedly questioned. There is no doubt that body weight is misleading in cirrhotic patients with ascites and/or oedema. In contrast, the impact of¯uid retention on arm anthropometric measurements is low and probably negligible on clinical grounds.
Nevertheless, different bedside body composition tools have been evaluated in recent years in cirrhotic patients for assessing malnutrition as an alternative to anthropometric parameters. Attempts with total body bioelectrical impedance analysis have been unsuccessful, mainly in patients with high volume ascites [2±4], whereas assessment of muscle function by means of electric stimulation has provided promising results [5] . Dual-energy X-ray absorptiometry (DEXA) is a safe noninvasive technique for assessing body composition according to a three compartment model allowing the evaluation of fat mass, bone mineral content, and lean mass [6, 7] . In addition, both whole body and regional analysis (arms, legs and trunk) may be performed. DEXA results have been validated in humans by comparison with other methods such as underwater weighing, skinfold thickness, bioelectrical impedance, total body water, total body potassium and total body nitrogen [8±11] . In healthy individuals, the concordance of DEXA with other methods is considered to be excellent for bone mineral content and very good for fat mass. In cirrhosis, DEXA has also been proven to be reliable for estimating whole body and regional body composition [1, 12] .
In the last year some contributions have been made to the evaluation of the usefulness of DEXA as a body composition measurement in cirrhosis. Haderslev et al. ] performed DEXA determinations in six cirrhotic patients before and after total volume paracentesis (median 6.8 L; ranging from 1.6 to 14.7 L). There were no signi®cant differences in bone mineral content (BMC) and bone mineral density (BMD) either in the spine (change in BMC = + 0.04%; change in BMD = 70.9%) or in the whole body (change in BMC = + 1.9%; change in BMD = + 0.4%). Moreover, changes in body composition after paracentesis were accurately detected by DEXA as a decrease in either total (median 75.8 kg, ranging from 2.0 to 16.1 kg) or trunk lean tissue mass (median 75.8 kg, ranging from 1.9 to 11.9 kg). Total and regional fat mass estimates were not in¯uenced by paracentesis. ] in a series of 37 patients with a wider spectrum of the disease (including either ascitic and non-ascitic, as well as Child±Pugh A, B and C patients). Mid-arm fat area, and DEXA-derived fat mass showed a close correlation (r = 0.85; P50.01) whereas this was poorer between mid-arm muscle area and lean tissue mass as assessed by DEXA (r = 0.32). Taken together, the results of these studies favour the use of anthropometry for nutritional assessment in cirrhosis.
Skinfold measurements seem to be particularly accurate to evaluate body fat mainly in patients without overt uid retention, but probably also in those with ascites. ].
Consequences of malnutrition in cirrhosis and liver transplantation
Malnutrition negatively in¯uences the outcome of cirrhotic patients. Short-term survival in cirrhosis has been proven to decrease in parallel to the severity of malnutrition [28, 29] . Moreover, multivariate analyses have disclosed some nutritional parameters as independent predictors of survival in these patients [30, 31] .
The negative impact of malnutrition in cirrhosis may be particularly inopportune in those patients undergoing a curative procedure for diseases such as orthotopic liver transplantation. Malnutrition is known to increase the morbidity and mortality after liver transplantation. In adults, this was reported ®fteen years ago in retrospective studies [32] . More recently, both preoperative hypermetabolism and body cell mass depletion were proven to be better predictors of the outcome of liver transplantation than the traditional Child-Pugh score [33, 34] . Undernutrition may lead to glycogen depletion and this has been suggested to increase the plasma lactate/pyruvate ratio during the anhepatic phase. It may also induce an exaggerated cytokine response thereby favouring the development of postoperative systemic in¯ammatory response syndrome and multiorgan failure in these patients [35] .
Besides its impact on general postoperative complications and survival in liver transplantation, malnutrition could also have a role in the development of graft rejection in these patients. To date, however, this issue has been scarcely investigated. In a retrospective study, Bathgate et al. [36 . ] aimed to identify preoperative predictors of acute allograft rejection in a cohort of 121 patients undergoing liver transplantation. Parameters such as age at transplantation, cause of liver disease, preoperative albumin and creatinine concentrations, anthropometric parameters, age of the donor, HLA DR mismatch, and cold ischemia time were evaluated. At univariate analysis, acute rejection was found to be more frequent in younger patients, those belonging to the Child±Pugh A class, and those with normal mid-arm muscle circumference. This is not surprising since old age, malnutrition and severity of liver failure are all causes of impaired immune response. Also, acute rejection was increased in liver recipients from donors younger than 30 or older than 50 years. Interestingly, on multivariate analysis, the only signi®cant predictor was the decreased likelihood of acute graft rejection in those patients with decreased mid-arm muscle circumference [36 . ]. According to these results, the negative role of malnutrition on the general outcome of liver transplantation appears to be, at least in part, counterbalanced by its immunosuppressive effect on rejection. Both aspects should be simultaneously assessed in large series of transplanted patients. In the meantime, the deleterious effects of malnutrition must prevail and efforts have to be made to improve nutritional status in liver transplant candidates [37] .
Metabolic changes after liver transplantation
Many of the nutritional derangements associated with end-stage liver disease improve after liver transplantation. For instance, low levels of vitamin A and zinc rapidly increase after transplantation [38, 39] . Also, increased protein turnover tends to normalize, total body water decreases and body fat increases within the 12 months following liver transplantation [40, 41] ]. Postoperative decrease in bone mineral density was more marked at the femoral neck (78.0+1.7%) than at the lumbar spine (72.0+1.2%). Interestingly, these patients showed a signi®cant reduction in lean body mass following transplantation whereas their body fat increased (accounting for a 12.2+2.3% gain in body weight) [54 . ]. Thus, postoperative bone loss at the femoral neck, coupled with a decrease in lean body (i.e. muscle) mass (which can predispose to falls), may contribute to the increased frequency of fractures after liver transplantation.
Treatment with corticosteroids, cyclosporine, and prolonged bed rest has been claimed to contribute to early post-transplantation bone loss [52] . However, rates of bone loss vary widely amongst patients with identical immunosuppressive regimens and similar periods of post-transplantation immobility, suggesting the existence of individual differences in the susceptibility to bone loss in these patients. In this sense, common allelic variants in the gene that encodes for the vitamin D receptor (locus B) have been reported to be associated with differences in bone mineral density and rate of bone loss [55±59] . The bb genotype is thought to protect against bone loss. In a very interesting article, Guardiola et al. [60 . . ] investigated the in¯uence of vitamin D receptor gene polymorphism on bone loss after liver transplantation. Genotype analysis of the B locus of the vitamin D receptor gene was performed in 55 patients undergoing liver transplantation. In 36 of them, the authors were able to evaluate bone mineral density by means of DEXA before and three, six, 12 and 24 months after transplantation. Forty percent of patients were homozygotic for the b allele (bb genotype), whereas 47% were heterozygotic (Bb genotype), and 13% homozygotic for the B allele (BB genotype). No differences in bone mineral density were found among groups before liver transplantation [60
. . ]. After adjusting for steroid intake and hospital stay, genetic polymorphism showed a signi®cant effect on post-transplantation bone loss. In patients with the Bb/BB genotypes, bone loss within the ®rst three postoperative months was 3.7% (95%CI: 0.6%±6.9%) greater than in patients with the bb genotype. In fact, bone mineral density decreased in this period in nine out of 16 patients (56%) with the bb genotype versus 19 out of 20 patients (95%) with the Bb/ BB genotypes (P = 0.01). [60
. . ]. In spite of the difference between groups it should be noted that there was also a high variability within groups. Thus, vitamin D receptor genetic polymorphism does not appear to determine the degree of bone loss after liver transplantation but only to modulate bone susceptibility to other factors (particularly steroid therapy). It is conceivable that the negative impact of the presence of the B allele (Bb or BB genotypes) in candidates for liver transplantation could be reversed by a high-calcium intake as it has been demonstrated in other clinical situations [61, 62] .
Fortunately, the short-term bone loss observed immediately after liver transplantation appears to be followed by a recovery in bone mass, but data are limited. This view is supported by the above mentioned study where bone mineral density recovered from three to 24 months after transplantation in the three genotypic groups, although the differences observed at three months persisted throughout the follow-up [60
. . ]. Furthermore, a recent long-term follow-up study in 28 patients surviving at least ®ve years after liver transplantation indicated that continued recovery of bone mineral density may occur for as long as seven years after transplantation [63 . ]. Moreover, elevated levels of parathyroid hormone and osteocalcin at the end of follow-up were found in nine out of 28 and 14 out of 27 cases respectively. This suggests a long-term continued bone remodelling at least in some liver transplanted patients [63 . ].
Nutritional therapy in cirrhosis
Conventional diet therapy is the main way for long-term nutritional support of patients with cirrhosis, thereby reducing the need for arti®cial nutrition. Adequate oral intake would reduce the need for arti®cial nutrition in these patients. Diet therapy has proven to be effective in cirrhosis in terms of energy [64, 65] and protein gains [66] .
There are several studies supporting the view that a modi®ed eating pattern with four to seven small meals, including at least one late evening carbohydrate-rich snack, improves nitrogen economy and partially reverses the abnormal substrate oxidation of cirrhotic patients [67±69]. In fact, such a modi®ed eating pattern has been included in some international recommendations for nutritional therapy in chronic liver disease [70] . However, the feasibility of these dietary modi®cations in cirrhosis is not well established, since there is only limited information about the spontaneous energy intake patterns in these patients. In this sense, a recent study in the UK investigating the daily distribution of energy intake in cirrhotic patients [71 . ] is particularly interesting. Eight cirrhotic patients and eight matched healthy volunteers kept weighted dietary intake records for several separate days over a six-month period. The records were analyzed for energy intake per hour and the number and size of energy intake episodes per day was calculated. Considerable inter-and intra-individual variations in the number and size of meals were observed both in patients and healthy controls, although there were no differences in the mean number of daily energy intake episodes between both groups [71 . ]. Most patients (and also healthy volunteers) tended to eat frequent small meals, including a late-evening snack, rather than two or three large meals, suggesting that implementing the optimum pattern of energy intake according to the late guidelines in cirrhosis would be feasible [71 . ]. However, the study involved a very small number of patients and it is uncertain whether its results could be extrapolated to other countries with different gastronomic and eating uses.
The use of supplements of chemically-de®ned enteral diets seems a priori to be a good therapeutic alternative for the long-term management of malnourished cirrhotics in whom the conventional diet alone is unable to improve their nutritional status. To date, only a controlled trial on the use of such supplements (1000 kcal and 35 g of nitrogen/day for one year) has been reported in alcoholic cirrhotics [72] . The need for hospitalization was signi®cantly lower in the supplemented group because of a reduction of infectious complications during the study period [72] . In addition, a marked but insigni®cant trend to a lower mortality in the therapeutic group was observed [72] .
Recently, the same authors have reported the outcome of a series of 31 male Child B and C alcoholic cirrhotics treated for six months with the same enteral supplement [73 . ]. REE, body fat mass, serum albumin, and cellular immunity improved signi®cantly during the period of study. Six patients died during the study period, ®ve of them from upper gastrointestinal bleeding [73 . ]. Unfortunately this was an uncontrolled trial, which very much decreases the strength of its conclusions. In fact, in the previous controlled trial the nutritional gains were similar in both supplement and placebo groups [72] .
Taking into account the prognostic signi®cance of malnutrition in cirrhosis and liver transplantation, the use of arti®cial nutrition (preferably enteral) is often required. As repeatedly stressed within our Current Opinion reviews [74, 75] , only ®ve randomized controlled trials on parenteral [76] or enteral nutrition [77±80] in advanced cirrhosis have been published. Similar studies on postoperative nutritional support after liver transplantation are also scarce [81±83] . No controlled trial on preoperative nutrition in transplantation candidates has yet been published.
In our two previous reviews in this journal [74, 75] we expressed the need for large-scale multicentred controlled trials which would allow us to answer some crucial questions in the ®eld of arti®cial nutrition in chronic liver disease and transplantation. Unfortunately, another year has elapsed and no such paper has been published.
Polyunsaturated fatty acid deficiency in liver disease and its treatment
Liver disease is one of the most important causes of polyunsaturated fatty acid (PUFA) de®ciency, since the synthesis of these compounds from their essential fatty acid (EFA) precursors occurs mostly in the liver. Several studies indicate that in advanced cirrhosis, plasma de®ciency of both EFA (linoleic and a-linolenic acids) and long-chain PUFA occur in the setting of an overall decrease in plasma fatty acid concentrations, which also includes saturated and monounsaturated compounds [84, 85] . However, since EFA and long-chain PUFA de®ciency are more marked, the unsaturation of plasma lipid fractions decreases [85] .
The effects of acute liver damage on plasma fatty acid pro®le has been scarcely investigated. This year, a study was published which investigated the fatty acid pattern of plasma phospholipids in stable cirrhotics (n = 7) compared with patients with chronic liver disease and acute hepatic encephalopathy (n = 6). In addition, it compared the same patterns in patients with acute liver failure (n = 10) with those of healthy controls (n = 11) [86 . ]. Patients with acute liver failure had lower EFA (mainly linoleic acid) and higher monounsaturated fatty acid (mainly oleic acid) percentages in plasma phospholipids than their healthy controls. However, patients did not show long-chain PUFA de®ciency. Similar differences were found between patients with chronic liver disease and acute encephalopathy and their stable cirrhotic controls. Thus, acute liver damage seems to induce EFA de®ciency in previously healthy individuals, and to aggravate such a de®cit in cirrhotics without further impairment of long-chain PUFA status [86 . ]. These latter ®ndings are in contrast to those of earlier studies where acute encephalopathy did not have any in¯uence on PUFA status in cirrhotic patients [87] .
PUFA de®ciency also involves blood and parenchymal cells in cirrhosis. Low levels of arachidonic acid (the major n-6, linoleic acid-derived PUFA) have been reported in erythrocytes [88, 89] and platelets [90, 91] of patients with several liver diseases including cirrhosis whereas decreased amounts of EFA have been described in the adipose tissue of cirrhotic patients [92] . Although there are no data on the fatty acid pro®le in parenchymal cells in cirrhosis, it is conceivable that they would also be PUFA de®cient.
Taking into account the important biological functions of PUFA, which contributes to the maintenance of thē uidity of cell membranes and to the release of a wide array of second messengers (including eicosanoids), some attempts at reversing PUFA de®ciency in cirrhosis have been made with poor results. Although never measured, the activity of hepatic desaturases is thought to be decreased in human cirrhosis. This view is supported by the ®nding of increased D-6 and D-5 desaturase precursor/products plasma molar ratios in these patients [84] .
Duerksen et al. [93 . ] have reported the failure of total parenteral nutrition containing Intralipid 1 (a soybean oil, linoleic acid-based lipid emulsion) to improve long-chain PUFA de®ciency in nine malnourished cirrhotics. In addition, Intralipid 1 infusion for a mean of eight days only achieved a modest improvement in plasma EFA in these patients [93 . ]. In fact these results are not new but con®rm previous data published more than a decade ago [94] . Moreover, feeding g-linolenic acid, the product of the action of D-6 desaturase upon linoleic acid, to cirrhotic patients for six weeks failed to increase the levels of arachidonic acid in plasma and platelets. This suggests that impaired PUFA biosynthesis in cirrhosis involves not only the ®rst (D-6) but also further (D-5) desaturation steps [95] . Accordingly, it has been claimed that restoring PUFA de®ciency would require the administration of longchain PUFA rather than their EFA precursors [96, 97] . In this sense, the recent report of improvements in plasma docosahexaenoic acid, an end product of the n-3 PUFA series, after supplementation with large doses of PUFAenriched capsules (containing 408 mg docosahexaenoic) in ®ve docosahexaenoic-de®cient alcoholic cirrhotics, is encouraging [98 . ].
Antioxidant status in chronic liver disease
The suitability of reversing PUFA de®ciency in cirrhosis has been questioned on the light of the increased susceptibility of unsaturated fat to peroxidation, so that PUFA de®ciency could be viewed as an adaptive phenomenon in these patients [99] . In fact, increased lipid peroxidation has been reported in cirrhotic patients, as assessed by malondialdehyde [100, 101] or 8-isoprostaglandin F 2a levels [102] .
In addition to undergoing increased oxidative stress, cirrhotic patients had impaired antioxidant defences. ]. No differences in antioxidant levels were found between both chronic cholestatic diseases. Antioxidant plasma levels were not affected by the severity of histological stage in primary biliary cirrhosis, but a negative correlation was found between total carotenoids and serum activity of both alkaline phosphatase and g-glutamyl-transpeptidase [110 . ]. These results indicate that biochemical antioxidant de®ciency occurs in early stages of chronic cholestatic diseases, suggesting the need for prompt supplementation in these patients.
Yasa et al. [111
. ] have assessed superoxide dismutase and glutathione peroxidase activities in the red blood cells of 38 patients with either alcoholic (n = 13) or viral cirrhosis (n = 25), compared with ten healthy controls. Both red blood cell superoxide dismutase and glutathione peroxidase activities were found to be signi®cantly lower in cirrhotics than in healthy controls [111 . ]. Interestingly, however, erythrocyte oxidative stress, as assessed by levels of thiobarbituric acid reactive substances, was not increased in these patients [111 . ]. Although red blood cell fatty acid composition was not assessed in this study, it is conceivable that PUFA de®ciency might contribute to protect the erythrocytes of these patients from oxidative stress. ] evaluated the effect of eating on plasma antioxidant capacity (PAC) in 18 cirrhotic patients and 18 healthy individuals. PAC was measured by¯uorometry after a 12-hour fasting and one, two and three hours after eating a drink formula diet. At fasting state (baseline) PAC was higher in alcoholic cirrhotics (847+39 mmol/l) than in patients with post-viral cirrhosis (653+41 mmol/l) or controls (758+26 mmol/l) (P50.005) [112 . . ]. In both alcoholic and post-viral cirrhotics, PAC did not change in the post-absorptive state whereas it progressively diminished in healthy controls (719+21 mmol/l at 3 h, P50.02) [112
. . ]. Thus, cirrhotic patients are unresponsive to the effects of feeding on plasma antioxidant capacity. Although the mechanism for this phenomenon is not known, it could possibly represent another adaptive mechanism to ®ght against the oxidative stress in cirrhosis.
Conclusion
Some papers scanned in this report are, in our opinion, important enough to emphasize their results in this closing section. The lack of agreement between measured and estimated REE (using a wide array of predictive equations) in a large series of cirrhotics [27
. . ] is noteworthy and strongly argues against the use of these predictive formulas to assess the energy requirements of these patients. To our knowledge, the ®rst direct evidence that liver transplantation normalizes insulin sensitivity and glucose disposal in cirrhosis was published during the last year [47 .
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